查看購物車
  • English
  • Japanese
細胞及基因治療工具及試劑：全球市場
市場調查報告書
商品編碼
1936026

細胞及基因治療工具及試劑：全球市場

Cell and Gene Therapy Tools and Reagents: Global Markets
出版日期: | 出版商: BCC Research | 英文 175 Pages | 訂單完成後即時交付

價格

全球細胞和基因治療工具及試劑市場預計將從 2025 年的 120 億美元成長到 2030 年底的 198 億美元，在預測期（2025-2030 年）內以 10.6% 的複合年成長率成長。

預計北美市場將從 2025 年的 52 億美元成長到 2030 年底的 92 億美元，在預測期（2025-2030 年）內以 12.1% 的複合年成長率成長。

歐洲市場預計將從 2025 年的 34 億美元成長到 2030 年底的 56 億美元，在預測期（2025-2030 年）內以 10.2% 的複合年成長率成長。

本報告調查了全球細胞和基因治療工具及試劑市場，並提供了市場概況、市場影響因素和市場機會分析、技術趨勢、法律制度、市場規模趨勢和預測、按各個細分市場和地區進行的詳細分析以及主要企業的概況。

目錄

第1章執行摘要

  • 市場展望
  • 調查範圍
  • 市場概況
  • 概述
  • 當前市場情勢
  • 細分市場分析
  • 區域市場洞察
  • 新興技術
  • 結論

第2章 市場概覽

  • 細胞和基因治療概述
  • 細胞療法
  • 基因治療
  • 細胞和基因治療的類型
  • 基因治療
  • 細胞療法
  • 常用設備
  • 已通過核准的細胞和基因治療產品
  • 宏觀經濟因素分析
  • 人口統計因素
  • 地緣政治因素
  • 美國關稅的影響
  • 波特五力分析

第3章 市場動態

  • 市場動態
  • 市場促進因素
  • 增加對CGT研究的投資
  • 擴大臨床和商業化 CGT 產品
  • 精準醫療的需求日益成長
  • 擴大臨床和商業生產能力
  • 加強策略性舉措
  • 人口老化和慢性病增加
  • 市場限制/挑戰
  • 複雜製造與供應鏈
  • 高昂的開發成本
  • 熟練勞動力短缺
  • 監管障礙
  • 市場機遇
  • 新興國家對資本利得稅的需求日益成長
  • 對成品的需求不斷成長

第4章：監理現狀

  • 概述
  • 美國
  • 細胞治療法規
  • 基因治療監管
  • 病毒載體和非病毒載體
  • 媒體
  • GMP蛋白和抗體
  • 白血球分離術
  • 歐洲
  • 亞太地區

第5章 新興科技與發展

  • 重點總結
  • 封閉式自動化系統
  • 一次性技術和小型化

第6章 市場區隔分析

  • 細分市場分析
  • 按產品類型分類的市場分析
  • 重點總結
  • 免疫檢測
  • 生物反應器
  • 白血球分離術
  • GMP抗體
  • 多重免疫檢測
  • 向量
  • 細胞分離
  • 冷凍保存
  • 細胞增殖
  • 媒體
  • GMP蛋白
  • GMP小分子
  • CRS監測
  • 市場分析：按應用領域
  • 重點總結
  • 癌症
  • 罕見疾病
  • 其他疾病
  • 按最終用戶分類的市場分析
  • 重點總結
  • 製藥和生物技術公司
  • 學術研究機構
  • 臨床實驗室
  • 地理細分
  • 按地區分類的市場分析
  • 重點總結
  • 北美洲
  • 歐洲
  • 亞太地區
  • 世界其他地區

第7章 競爭訊息

  • 重點總結
  • 競爭分析
  • 策略舉措
  • 合約、合作與夥伴關係
  • 獲得
  • 投資與擴張

8. 全球細胞和基因治療工具及試劑市場的永續性：ESG視角

  • ESG簡介
  • 永續性趨勢與企業舉措
  • 環境因素
  • 社會因素
  • 管治因素
  • 社會與管治計劃
  • 結論

第9章附錄

  • 調查方法
  • 來源
  • 簡稱
  • 公司簡介
  • ABCAM LTD.
  • ADVERUM BIOTECHNOLOGIES INC.
  • AKRON BIOTECH
  • BIO-RAD LABORATORIES INC.
  • BIO-TECHNE
  • CYTIVA
  • FUJIFILM IRVINE SCIENTIFIC (FUJIFILM BIOSCIENCES)
  • MERCK KGAA
  • MILTENYI BIOTEC
  • PROTEINTECH GROUP INC.
  • QIAGEN
  • REVVITY
  • SARTORIUS AG
  • STEMCELL TECHNOLOGIES
  • THERMO FISHER SCIENTIFIC INC.
  • 新興Start-Ups/市場顛覆者
Product Code: BIO208D

The global market for cell and gene therapy tools and reagents is expected to grow from $12 billion in 2025 and is projected to reach $19.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 10.6% during the forecast period of 2025 to 2030.

The North American market for cell and gene therapy tools and reagents is expected to grow from $5.2 billion in 2025 and is projected to reach $9.2 billion by the end of 2030, at a CAGR of 12.1% during the forecast period of 2025 to 2030.

The European market for cell and gene therapy tools and reagents is expected to grow from $3.4 billion in 2025 and is projected to reach $5.6 billion by the end of 2030, at a CAGR of 10.2% during the forecast period of 2025 to 2030.

Report Scope

The report provides an overview of the global market for cell and gene therapy tools and reagents. It includes global revenue ($ millions) for the base year 2024, estimated data for 2025, and forecast data from 2026 through 2030. In this report, the market is segmented based on product type, application and end user. By product type, the market is segmented into vectors, GMP proteins, GMP antibodies, GMP small molecules, bioreactors, multiplex immunoassays, immunoassays, leukapheresis, cell separation, cell expansion, cytokine release syndrome (CRS) monitoring, cryopreservation and media.

The application segment covered cancer, rare diseases and other diseases. By end user, the market is divided into pharmaceutical and biotechnology companies, academic research institutes, and clinical laboratories.

The regions covered in this study are North America, Europe, Asia-Pacific and rest of the World (RoW) (which includes the Middle East and Africa and South America), with analysis of the markets in the U.S., Canada, Mexico, Germany, the U.K., Italy, France, Spain, the rest of Europe, China, Japan, India, South Korea and the rest of Asia-Pacific. The report covers the trends and challenges that affect the market. It includes an analysis of the competitive landscape, with the ranking of leading companies and their market shares. The report also has a dedicated section of company profiles that covers details of leading companies. It analyzes companies' environmental, social and corporate governance (ESG) initiatives.

Report Includes

  • 77 data tables and 55 additional tables
  • An overview of the global market for cell and gene therapy tools and reagents
  • In-depth analysis of global market trends, featuring historical revenue data for 2022-2025. This analysis includes projections of compound annual growth rates (CAGRs) through 2030
  • Evaluation of the current market size and revenue growth prospects specific to the cell and gene therapy tools and reagents market, accompanied by a market share analysis by type, application, end user, and region
  • Analysis of current and future demand in the cell and gene therapy tools and reagents market, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
  • Discussion of the prevalence of infectious disease, metabolic disorders and chronic ailments, along with the recent technological advances, competitive landscape, and the industry value chain
  • Analysis of drivers, challenges, and opportunities affecting market growth
  • Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, regulatory framework and reimbursement scenarios, and ESG trends of the market
  • Market share analysis of the key market participants in the industry, along with their research priorities, product portfolios, global rankings and company competitive landscape
  • Profiles of major companies within the industry, including Thermo Fisher Scientific Inc., Cytiva (Danaher Corp.), Merck KGaA, Miltenyi Biotec, and Sartorius AG

Table of Contents

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of Report
  • Market Summary
  • Overview
  • Current Market Scenario
  • Segmental Analysis
  • Regional Market Insights
  • Emerging Technologies
  • Conclusion

Chapter 2 Market Overview

  • Cell and Gene Therapy Overview
  • Cell Therapy
  • Gene Therapy
  • Types of Cell and Gene Therapy
  • Gene Therapy
  • Cell Therapy
  • Common Equipment Used
  • Approved Cell and Gene Therapy Products
  • Macroeconomic Factors Analysis
  • Demographic Factors
  • Geopolitical Factors
  • Impact of U.S. Tariffs
  • Porter's Five Forces Analysis

Chapter 3 Market Dynamics

  • Market Dynamics
  • Market Drivers
  • Increasing Investments in CGT Research
  • Expanding Clinical and Commercial CGT Products
  • Rising Demand for Precision Medicine
  • Capacity Expansions for Clinical and Commercial Manufacturing
  • Growing Number of Strategic Initiatives
  • Rising Aging Population and the Increasing Prevalence of Chronic Diseases
  • Market Restraints/Challenges
  • Complex Manufacturing and Supply Chain
  • High Cost of Development
  • Lack of Skilled Workforce
  • Regulatory Hurdles
  • Market Opportunities
  • Rising Demand for CGTs in Emerging Countries
  • Growing Demand for Off-the-Shelf Products

Chapter 4 Regulatory Landscape

  • Overview
  • U.S.
  • Cell Therapy Regulations
  • Gene Therapy Regulations
  • Viral and Non-Viral Vectors
  • Media
  • GMP Proteins and Antibodies
  • Leukapheresis
  • Europe
  • Asia-Pacific

Chapter 5 Emerging Technologies and Developments

  • Key Takeaways
  • Closed and Automated Systems
  • Single-Use Technologies and Miniaturization

Chapter 6 Market Segmentation Analysis

  • Segmentation Breakdown
  • Market Analysis by Product Type
  • Key Takeaways
  • Immunoassays
  • Bioreactors
  • Leukapheresis
  • GMP Antibodies
  • Multiplex Immunoassays
  • Vectors
  • Cell Separation
  • Cryopreservation
  • Cell Expansion
  • Media
  • GMP Proteins
  • GMP Small Molecules
  • CRS Monitoring
  • Market Analysis by Application
  • Key Takeaways
  • Cancer
  • Rare Diseases
  • Other Diseases
  • Market Analysis by End User
  • Key Takeaways
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Clinical Laboratories
  • Geographic Breakdown
  • Market Analysis by Region
  • Key Takeaways
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Chapter 7 Competitive Intelligence

  • Key Takeaways
  • Competitive Analysis
  • Strategic Initiatives
  • Agreements, Collaborations and Partnerships
  • Acquisitions
  • Investments and Expansions

Chapter 8 Sustainability in Global Market for Cell and Gene Therapy Tools and Reagents: An ESG Perspective

  • Introduction to ESG
  • Sustainability Trends and Company Initiatives
  • Environmental Factors
  • Social Factors
  • Governance Factors
  • Social and Governance Initiatives
  • Concluding Remarks

Chapter 9 Appendix

  • Research Methodology
  • Sources
  • Abbreviations
  • Company Profiles
  • ABCAM LTD.
  • ADVERUM BIOTECHNOLOGIES INC.
  • AKRON BIOTECH
  • BIO-RAD LABORATORIES INC.
  • BIO-TECHNE
  • CYTIVA
  • FUJIFILM IRVINE SCIENTIFIC (FUJIFILM BIOSCIENCES)
  • MERCK KGAA
  • MILTENYI BIOTEC
  • PROTEINTECH GROUP INC.
  • QIAGEN
  • REVVITY
  • SARTORIUS AG
  • STEMCELL TECHNOLOGIES
  • THERMO FISHER SCIENTIFIC INC.
  • Emerging Startups/Market Disruptors

List of Tables

  • Summary Table : Global Market for Cell and Gene Therapy Tools and Reagents, by Region, Through 2030
  • Table 1 : Approved Cell and Gene Therapy Products, as of October 2025
  • Table 2 : Incidence and Mortality Rates of Cancer Across Regions, 2022
  • Table 3 : Regulations for Advanced Therapies in the Asia-Pacific Region, 2025
  • Table 4 : Global Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
  • Table 5 : Global Market for Cell and Gene Therapy Tools and Reagents for Immunoassays, by Region, Through 2030
  • Table 6 : Global Market for Cell and Gene Therapy Tools and Reagents for Bioreactors, by Region, Through 2030
  • Table 7 : Global Market for Cell and Gene Therapy Tools and Reagents for Leukapheresis, by Region, Through 2030
  • Table 8 : Global Market for Cell and Gene Therapy Tools and Reagents for GMP Antibodies, by Region, Through 2030
  • Table 9 : Global Market for Cell and Gene Therapy Tools and Reagents for Multiplex Immunoassays, by Region, Through 2030
  • Table 10 : Global Market for Cell and Gene Therapy Tools and Reagents for Vectors, by Region, Through 2030
  • Table 11 : Global Market for Cell and Gene Therapy Tools and Reagents for Cell Separation, by Region, Through 2030
  • Table 12 : Global Market for Cell and Gene Therapy Tools and Reagents for Cryopreservation, by Region, Through 2030
  • Table 13 : Global Market for Cell and Gene Therapy Tools and Reagents for Cell Expansion, by Region, Through 2030
  • Table 14 : Global Market for Cell and Gene Therapy Tools and Reagents for Media, by Region, Through 2030
  • Table 15 : Global Market for Cell and Gene Therapy Tools and Reagents for GMP Proteins, by Region, Through 2030
  • Table 16 : Global Market for Cell and Gene Therapy Tools and Reagents for GMP Small Molecules, by Region, Through 2030
  • Table 17 : Global Market for Cell and Gene Therapy Tools and Reagents for CRS Monitoring, by Region, Through 2030
  • Table 18 : Global Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
  • Table 19 : Global Market for Cell and Gene Therapy Tools and Reagents for Cancer, by Region, Through 2030
  • Table 20 : Global Market for Cell and Gene Therapy Tools and Reagents for Rare Diseases, by Region, Through 2030
  • Table 21 : Global Market for Cell and Gene Therapy Tools and Reagents for Other Diseases, by Region, Through 2030
  • Table 22 : Global Market for Cell and Gene Therapy Tools and Reagents, by End User, Through 2030
  • Table 23 : Global Market for Cell and Gene Therapy Tools and Reagents for Pharmaceutical and Biotechnology Companies, by Region, Through 2030
  • Table 24 : Global Market for Cell and Gene Therapy Tools and Reagents for Academic and Research Institutes, by Region, Through 2030
  • Table 25 : Global Market for Cell and Gene Therapy Tools and Reagents for Clinical Laboratories, by Region, Through 2030
  • Table 26 : Global Market for Cell and Gene Therapy Tools and Reagents, by Region, Through 2030
  • Table 27 : North American Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
  • Table 28 : North American Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
  • Table 29 : North American Market for Cell and Gene Therapy Tools and Reagents, by End User, Through 2030
  • Table 30 : North American Market for Cell and Gene Therapy Tools and Reagents, by Country, Through 2030
  • Table 31 : U.S. Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
  • Table 32 : U.S. Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
  • Table 33 : Canadian Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
  • Table 34 : Canadian Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
  • Table 35 : Mexican Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
  • Table 36 : Mexican Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
  • Table 37 : European Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
  • Table 38 : European Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
  • Table 39 : European Market for Cell and Gene Therapy Tools and Reagents, by End User, Through 2030
  • Table 40 : European Market for Cell and Gene Therapy Tools and Reagents, by Country, Through 2030
  • Table 41 : German Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
  • Table 42 : German Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
  • Table 43 : U.K. Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
  • Table 44 : U.K. Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
  • Table 45 : French Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
  • Table 46 : French Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
  • Table 47 : Spanish Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
  • Table 48 : Spanish Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
  • Table 49 : Italian Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
  • Table 50 : Italian Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
  • Table 51 : Rest of Europe Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
  • Table 52 : Rest of Europe Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
  • Table 53 : Asia-Pacific Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
  • Table 54 : Asia-Pacific Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
  • Table 55 : Asia-Pacific Market for Cell and Gene Therapy Tools and Reagents, by End User, Through 2030
  • Table 56 : Asia-Pacific Market for Cell and Gene Therapy Tools and Reagents, by Country, Through 2030
  • Table 57 : Chinese Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
  • Table 58 : Chinese Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
  • Table 59 : Japanese Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
  • Table 60 : Japanese Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
  • Table 61 : Indian Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
  • Table 62 : Indian Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
  • Table 63 : South Korean Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
  • Table 64 : South Korean Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
  • Table 65 : Rest of Asia-Pacific Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
  • Table 66 : Rest of Asia-Pacific Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
  • Table 67 : RoW Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
  • Table 68 : RoW Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
  • Table 69 : RoW Market for Cell and Gene Therapy Tools and Reagents, by End User, Through 2030
  • Table 70 : RoW Market for Cell and Gene Therapy Tools and Reagents, by Sub-Region, Through 2030
  • Table 71 : Global Ranking of Companies: Cell and Gene Therapy Tools and Reagents Market, 2024
  • Table 72 : Agreements, Collaborations and Partnerships: Global Market for Cell and Gene Therapy Tools and Reagents, 2021 - 2025
  • Table 73 : Acquisitions: Global Market for Cell and Gene Therapy Tools and Reagents, 2022 - 2025
  • Table 74 : VC Investments and Expansion Activities: Global Market for Cell and Gene Therapy Tools and Reagents, 2022 - 2025
  • Table 75 : ESG: Environmental Overview
  • Table 76 : Key Social and Governance Issues in the Global Market for Cell and Gene Therapy Tools and Reagents
  • Table 77 : Information Sources Used for this Report
  • Table 78 : Abbreviations Used in this Report
  • Table 79 : Abcam Ltd.: Company Snapshot
  • Table 80 : Abcam Ltd.: Product Portfolio
  • Table 81 : Abcam Ltd.: News/Key Developments, 2022 - 2023
  • Table 82 : Adverum Biotechnologies Inc.: Company Snapshot
  • Table 83 : Adverum Biotechnologies Inc.: Financial Performance, FY 2023 and 2024
  • Table 84 : Adverum Biotechnologies Inc.: Product Portfolio
  • Table 85 : Adverum Biotechnologies Inc.: News/Key Developments, 2022 - 2025
  • Table 86 : Akron Biotech: Company Snapshot
  • Table 87 : Akron Biotech: Product Portfolio
  • Table 88 : Akron Biotech: News/Key Developments, 2022 - 2025
  • Table 89 : Bio-Rad Laboratories Inc.: Company Snapshot
  • Table 90 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2023 and 2024
  • Table 91 : Bio-Rad Laboratories Inc.: Product Portfolio
  • Table 92 : Bio-Rad Laboratories Inc.: News/Key Developments, 2021 - 2025
  • Table 93 : Bio-Techne: Company Snapshot
  • Table 94 : Bio-Techne: Financial Performance, FY 2023 and 2024
  • Table 95 : Bio-Techne: Product Portfolio
  • Table 96 : Bio-Techne: News/Key Developments, 2022 - 2025
  • Table 97 : Cytiva: Company Snapshot
  • Table 98 : Cytiva: Product Portfolio
  • Table 99 : Cytiva: News/Key Developments, 2021 - 2024
  • Table 100 : FUJIFILM Irvine Scientific (FUJIFILM Biosciences): Company Snapshot
  • Table 101 : FUJIFILM Irvine Scientific (FUJIFILM Biosciences): Product Portfolio
  • Table 102 : FUJIFILM Irvine Scientific (FUJIFILM Biosciences) : News/Key Developments, 2022 - 2025
  • Table 103 : Merck KGaA: Company Snapshot
  • Table 104 : Merck KGaA: Financial Performance, FY 2023 and 2024
  • Table 105 : Merck KGaA: Product Portfolio
  • Table 106 : Merck KGaA: News/Key Developments, 2023 - 2025
  • Table 107 : Miltenyi Biotec: Company Snapshot
  • Table 108 : Miltenyi Biotec: Product Portfolio
  • Table 109 : Miltenyi Biotec: News/Key Developments, 2023 - 2024
  • Table 110 : Proteintech Group Inc.: Company Snapshot
  • Table 111 : Proteintech Group Inc.: Product Portfolio
  • Table 112 : Qiagen: Company Snapshot
  • Table 113 : Qiagen: Financial Performance, FY 2023 and 2024
  • Table 114 : Qiagen: Product Portfolio
  • Table 115 : Qiagen: News/Key Developments, 2023 - 2024
  • Table 116 : Revvity: Company Snapshot
  • Table 117 : Revvity: Financial Performance, FY 2023 and 2024
  • Table 118 : Revvity: Product Portfolio
  • Table 119 : Revvity: News/Key Developments, 2023 - 2025
  • Table 120 : Sartorius AG: Company Snapshot
  • Table 121 : Sartorius AG: Financial Performance, FY 2023 and 2024
  • Table 122 : Sartorius AG: Product Portfolio
  • Table 123 : Sartorius AG: News/Key Developments, 2023 - 2024
  • Table 124 : STEMCELL Technologies: Company Snapshot
  • Table 125 : STEMCELL Technologies: Product Portfolio
  • Table 126 : STEMCELL Technologies: News/Key Developments, 2022 - 2025
  • Table 127 : Thermo Fisher Scientific Inc.: Company Snapshot
  • Table 128 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
  • Table 129 : Thermo Fisher Scientific Inc.: Product Portfolio
  • Table 130 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022 - 2025
  • Table 131 : Emerging Startups in the Global Market for Cell and Gene Therapy Tools and Reagents

List of Figures

  • Summary Figure : Global Market Shares for Cell and Gene Therapy Tools and Reagents, by Region, 2024
  • Figure 1 : Porter's Five Forces Analysis of the Global Market for Cell and Gene Therapy Tools and Reagents
  • Figure 2 : Market Dynamics Snapshot of Cell and Gene Therapy Tools and Reagents
  • Figure 3 : Market Investments for Cell and Gene Therapy, by Year, 2019-2024
  • Figure 4 : Market Investments for Cell and Gene Therapy, by Deal Type, H1 2025
  • Figure 5 : Global Market Shares for Cell and Gene Therapy Tools and Reagents, by Product Type, 2024
  • Figure 6 : Global Market Shares for Cell and Gene Therapy Tools and Reagents, by Application, 2024
  • Figure 7 : Global Market Shares for Cell and Gene Therapy Tools and Reagents, by End User, 2024
  • Figure 8 : Global Market Shares for Cell and Gene Therapy Tools and Reagents, by Region, 2024
  • Figure 9 : North American Market Shares for Cell and Gene Therapy Tools and Reagents, by Country, 2024
  • Figure 10 : European Market Shares for Cell and Gene Therapy Tools and Reagents, by Country, 2024
  • Figure 11 : Asia-Pacific Market Shares for Cell and Gene Therapy Tools and Reagents, by Country, 2024
  • Figure 12 : RoW Market Shares for Cell and Gene Therapy Tools and Reagents, by Sub-Region, 2024
  • Figure 13 : Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, FY 2024
  • Figure 14 : Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, FY 2024
  • Figure 15 : Bio-Techne: Revenue Shares, by Business Unit, FY 2024
  • Figure 16 : Bio-Techne: Revenue Shares, by Country/Region, FY 2024
  • Figure 17 : Merck KGaA: Revenue Shares, by Business Unit, FY 2024
  • Figure 18 : Merck KGaA: Revenue Shares, by Country/Region, FY 2024
  • Figure 19 : Qiagen: Revenue Shares, by Business Unit, FY 2024
  • Figure 20 : Qiagen: Revenue Shares, by Country/Region, FY 2024
  • Figure 21 : Revvity: Revenue Shares, by Business Unit, FY 2024
  • Figure 22 : Revvity: Revenue Shares, by Country/Region, FY 2024
  • Figure 23 : Sartorius AG: Revenue Shares, by Business Unit, FY 2024
  • Figure 24 : Sartorius AG: Revenue Shares, by Country/Region, FY 2024
  • Figure 25 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2024
  • Figure 26 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2024